Nipent
Active substance: pentostatin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · PENTOSTATIN 2 mg/mL
United StatesActive
Marketing holder: Hospira, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PENTOSTATIN · 2 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-c1cf-7e8d-9019-abd62744983f;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0409-0801
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0409-0801 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0409-0801 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0409-0801 · Verified 2026-10-09 · open in source